|
Spironolactone (125 mg) |
1952/1/7 |
1619006 |
USP |
詳細を見る
|
|
Spironolactone Epimer Mixture (30 mg) (7-Epispironolactone approximately 56% an… |
N/A |
1619051 |
USP |
詳細を見る
|
|
Spironolactone Related Compound A (100 mg) ((2’R)-3′,4′-Dihyd… |
976-71-6 |
1619017 |
USP |
詳細を見る
|
|
Spironolactone Related Compound B (30 mg) ((2’R)-7alpha-(Acetylthio)-5… |
132458-33-4 |
1619028 |
USP |
詳細を見る
|
|
Spironolactone Related Compound C (30 mg) ((2’R)-3′,4′-Dihydr… |
976-70-5 |
1619039 |
USP |
詳細を見る
|
|
Spironolactone Related Compound D (30 mg) ((2’R)-7alpha-(Acetyldisulfanyl… |
N/A |
1619040 |
USP |
詳細を見る
|
|
Spironolactone Related Compound I (30 mg) (S-[17alpha-(Ethoxymethyl)-17-hydroxy… |
N/A |
1619094 |
USP |
詳細を見る
|
|
Sodium Trifluoroacetate (500 mg) |
2923-18-4 |
1615138 |
USP |
詳細を見る
|
|
Solifenacin Identification Mixture A (15 mg) |
N/A |
1615311 |
USP |
詳細を見る
|
|
Solifenacin Identification Mixture B (20 mg) |
N/A |
1615322 |
USP |
詳細を見る
|
